Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Jul 29, 2022

SELL
$123.25 - $186.24 $211,004 - $318,842
-1,712 Closed
0 $0
Q1 2022

May 02, 2022

SELL
$126.25 - $231.85 $295,425 - $542,529
-2,340 Reduced 57.75%
1,712 $292,000
Q4 2021

Oct 02, 2024

BUY
$216.64 - $362.52 $788,569 - $1.32 Million
3,640 New
3,640 $938,000
Q4 2021

Oct 01, 2024

BUY
$216.64 - $362.52 $788,569 - $1.32 Million
3,640 New
3,640 $938,000
Q4 2021

Jan 24, 2022

BUY
$216.64 - $362.52 $43,328 - $72,504
200 Added 5.19%
4,052 $1.05 Million
Q3 2021

Oct 01, 2024

BUY
$205.93 - $447.23 $749,585 - $1.63 Million
3,640 New
3,640 $994,000
Q3 2021

Oct 28, 2021

BUY
$205.93 - $447.23 $16,886 - $36,672
82 Added 2.18%
3,852 $1.05 Million
Q2 2021

Oct 02, 2024

BUY
$113.32 - $241.49 $423,816 - $903,172
3,740 New
3,740 $837,000
Q2 2021

Jul 23, 2021

SELL
$113.32 - $241.49 $245,904 - $524,033
-2,170 Reduced 36.53%
3,770 $844,000
Q1 2021

Oct 02, 2024

BUY
$85.73 - $119.5 $574,391 - $800,650
6,700 New
6,700 $732,000
Q1 2021

May 05, 2021

SELL
$85.73 - $119.5 $62,582 - $87,235
-730 Reduced 10.94%
5,940 $649,000
Q4 2020

Oct 02, 2024

BUY
$72.71 - $129.54 $458,072 - $816,102
6,300 New
6,300 $514,000
Q4 2020

Jan 27, 2021

BUY
$72.71 - $129.54 $484,975 - $864,031
6,670 New
6,670 $544,000

Others Institutions Holding BNTX

About BioNTech SE


  • Ticker BNTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 242,684,992
  • Market Cap $28B
  • Description
  • BioNTech SE, a biotechnology company, develops and commercializes immunotherapies for cancer and other infectious diseases. The company is developing FixVac product candidates, including BNT111, which is in Phase II clinical trial for advance melanoma; BNT112 that is in Phase I/IIa clinical trial for prostate cancer; BNT113, which is in Phase II...
More about BNTX
Track This Portfolio

Track Commerzbank Aktiengesellschaft Portfolio

Follow Commerzbank Aktiengesellschaft and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Commerzbank Aktiengesellschaft , based on Form 13F filings with the SEC.

News

Stay updated on Commerzbank Aktiengesellschaft with notifications on news.